Identification of optimal conditions for the expansion of human bone marrow-derived mesenchymal stem cells using tools for live-cell culture monitoring

Based on the results of our study, we have developed recommendations regarding cell culture media composition for the expansion of human bone marrow-derived mesenchymal stem cells (MSC) for preclinical studies and potential clinical applications. ALPHA-MEM supplemented with 10% platelet lysate proved to be the most effective culture medium. Different DMEM media supplemented with fetal bovine serum turned out to be less effective: a maximum of 80% confluence was reached after 80 hours of culture, while MSC confluence in StemMACS and ALPHA-MEM media supplemented with platelet lysate kept increasing even after 100 hours of expansion. The growth rate of MSCs in RPMI-1640 medium was significantly lower than in the other culture media. When culturing MSCs in media with high glucose concentration (4.5 g/L), the percentage of cells with fat transformation after 5 days of culture was higher than in low-glucose (1.0 g/L) media such as DMEM low gl, StemMacs, ALPHAMEM. It is preferable to use MSC expansion media that do not induce spontaneous adipogenic differentiation for culturing MSCs for clinical purposes because the cells remain uncommitted and all their differentiation potential can be used in accordance with the objectives of further research and/or clinical needs. This study was supported by the local Ethics Committee and approved by the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. All the participants signed the standard informed consent form and agreed to the use of some of their biological materials for research purposes.

Authors

Institutions

Publication Details

Journal
Pediatric Hematology/Oncology and Immunopathology
Published
2024-12-13
DOI
https://doi.org/10.24287/1726-1708-2024-23-4-78-83
Primary Topic
Mesenchymal stem cell research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identification of optimal conditions for the expansion of human bone marrow-derived mesenchymal stem cells using tools for live-cell culture monitoring

Elena Osipova, Rimma Khismatullina, M. A. Ilushina, Alesja Dudorova et al.
Pediatric Hematology/Oncology and Immunopathology
Mesenchymal stem cell research
article

Identification of optimal conditions for the expansion of human bone marrow-derived mesenchymal stem cells using tools for live-cell culture monitoring

Elena Osipova, Rimma Khismatullina, M. A. Ilushina, Alesja Dudorova, В. В. Киселева, Michael Maschan, Irina Kazmina
article en

Abstract

Based on the results of our study, we have developed recommendations regarding cell culture media composition for the expansion of human bone marrow-derived mesenchymal stem cells (MSC) for preclinical studies and potential clinical applications. ALPHA-MEM supplemented with 10% platelet lysate proved to be the most effective culture medium. Different DMEM media supplemented with fetal bovine serum turned out to be less effective: a maximum of 80% confluence was reached after 80 hours of culture, while MSC confluence in StemMACS and ALPHA-MEM media supplemented with platelet lysate kept increasing even after 100 hours of expansion. The growth rate of MSCs in RPMI-1640 medium was significantly lower than in the other culture media. When culturing MSCs in media with high glucose concentration (4.5 g/L), the percentage of cells with fat transformation after 5 days of culture was higher than in low-glucose (1.0 g/L) media such as DMEM low gl, StemMacs, ALPHAMEM. It is preferable to use MSC expansion media that do not induce spontaneous adipogenic differentiation for culturing MSCs for clinical purposes because the cells remain uncommitted and all their differentiation potential can be used in accordance with the objectives of further research and/or clinical needs. This study was supported by the local Ethics Committee and approved by the Scientific Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation. All the participants signed the standard informed consent form and agreed to the use of some of their biological materials for research purposes.

Pediatric Hematology/Oncology and ImmunopathologyVol. 23(4)
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology (RU)
Openalex Percentile: Top 53%
Mesenchymal stem cell research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.